Cargando…
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences
Psoriasis is a common inflammatory skin disease characterized by the appearance of red scaly plaques that can affect any part of the body. High prevalence, chronicity, disfiguration, disability, and associated comorbidity make it a challenge for clinicians of multiple specialties. Likewise, its comp...
Autor principal: | Boehncke, Wolf-Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895645/ https://www.ncbi.nlm.nih.gov/pubmed/29675020 http://dx.doi.org/10.3389/fimmu.2018.00579 |
Ejemplares similares
-
IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
por: von Stebut, Esther, et al.
Publicado: (2020) -
Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2023) -
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2018) -
Efalizumab in the treatment of psoriasis
por: Boehncke, Wolf-Henning
Publicado: (2007) -
T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities
por: Casciano, Fabio, et al.
Publicado: (2018)